Immunogen’s CEO comments on Q2 earnings
- Jul 31, 2023
- 1 min read
Mark Enyedy discusses how the launch of the antibody-drug conjugate Elahere in platinum resistant ovarian cancer is progressing.
Also look for unique social pages for BiotechTV U.
HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.
Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.